SCHEMBL7042415

SCHEMBL7042415

CCCc1c(OCCCSc2ccc(CC(=O)OC)cc2Cl)ccc2c(CC)nsc12

nearest known ligand 0.62

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 15/20 0.62
PPARG P37231 14/20 0.62
PPARA Q07869 14/20 0.62
NR1H2 P55055 6/20 0.54
NR1H3 Q13133 6/20 0.54
ACACB O00763 1/20 0.35
CNR2 P34972 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7039665 0.92 PPARD (0.73) PPARDPPARGPPARANR1H2NR1H3
SCHEMBL7040035 0.85 PPARD (0.85) PPARDPPARGPPARANR1H2NR1H3
SCHEMBL7040931 0.85 PPARA (0.53) PPARDPPARGPPARANR1H2NR1H3
SCHEMBL8669133 0.84 PPARG (0.53) PPARDPPARGPPARANR1H2NR1H3
SCHEMBL7044857 0.82 PPARD (0.78) PPARDPPARGPPARANR1H2NR1H3
SCHEMBL7044865 0.82 PPARG (0.54) PPARDPPARGPPARANR1H2NR1H3
SCHEMBL6560656 0.81 PPARD (0.85) PPARDPPARGPPARANR1H2NR1H3
SCHEMBL7040439 0.81 PPARD (0.71) PPARDPPARGPPARANR1H2NR1H3
SCHEMBL7041349 0.80 PPARD (0.70) PPARDPPARGPPARANR1H2NR1H3
SCHEMBL6559861 0.80 PPARD (0.67) PPARDPPARGPPARANR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882029-B1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO INC (US) 2003-04-02 EP disclosed
US-6090836-A DIETETICS; ADJUSTMENT OF TRIGLYCERIDE CONCENTRATION MERCK & CO., INC. (US) 2000-07-18 US disclosed
EP-0882029-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS Merck & Co., Inc. (US) 1998-12-09 EP disclosed
WO-1997028137-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO., INC. (US) 1997-08-07 WO disclosed